TY - JOUR
T1 - Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome :
T2 - Jejunal Barrier Alterations Underlying Clinical Manifestations
AU - Pardo-Camacho, Cristina
AU - Ganda Mall, John-Peter
AU - Martínez, Cristina
AU - Pigrau Pastor, Marc
AU - Expósito, Elba
AU - Albert-Bayo, Mercé
AU - Melón-Ardanaz, Elisa
AU - Nieto Ruiz, Adoración
AU - Rodiño-Janeiro, Bruno
AU - Fortea, Marina
AU - Guagnozzi, Danila
AU - Rodríguez-Urrutia, Amanda
AU - de Torres, Inés
AU - Santos-Briones, Ignacio
AU - Azpiroz Vidaur, Fernando
AU - Lobo Álvarez, Beatriz
AU - Alonso Cotoner, Carmen
AU - Santos, Javier
AU - González Castro, Ana Maria
AU - Vicario Perez, Maria
PY - 2022
Y1 - 2022
N2 - Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology.
AB - Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology.
KW - Intestinal plasma cells
KW - Intestinal glycocalyx
KW - IBS-D
KW - Mucosal ultrastructure
KW - Intestinal barrier dysfunction
KW - Mucosal nerve fibres
U2 - 10.3390/cells11132046
DO - 10.3390/cells11132046
M3 - Article
C2 - 35805133
SN - 2073-4409
VL - 11
JO - Cells
JF - Cells
ER -